HKS Welcomes Rich Smith as Life Science Practice Director
HKS has announced that Rich Smith has joined the firm as a Principal and Life Science Practice Director. Based in the HKS Chicago office, Smith will be responsible for directing the firm’s growing Life Science business globally.
“The Life Science market is experiencing unprecedented innovation and growth, and Rich’s expertise gives us a tremendous competitive edge,” said HKS President and CEO Dan Noble. “The design of facilities that foster scientific discovery is so critical, now more than ever. This amplifies our intent to support our clients by creating spaces that spark creativity, inspire innovation, and foster collaboration.”
“The design of facilities that foster scientific discovery is so critical, now more than ever. This amplifies our intent to support our clients by creating spaces that spark creativity, inspire innovation, and foster collaboration.”
Rich is highly recognized within the industry and has more than 35 years of experience working with higher education, corporate/commercial, governmental and health care clients. His work includes public and private science and technology projects designing life sciences, physical sciences, engineering research, educational facilities, and R&D campuses. Rich has numerous speaking engagements to his credit including SCUP National Conference, AIA National Conference and the National Institutes of Health. He joins HKS from HGA.
“Throughout my career, I have respected HKS for their design leadership and innovative culture,” said Rich Smith. “I look forward to working with my new team to create the most successful science and technology venues in the industry. HKS’ commitment to design excellence, technical delivery and client relationships positions us to not only expand our Life Science practice but also to develop new collaborations with adjacent sectors like Health, Education and Commercial.”
Current HKS Life Science projects include a biomedical campus innovation center for Wexford Science & Technology and Arizona State University, a new musculoskeletal institute for Emory University and a state-of-the-art lab for the Food and Drug Administration.